Optimizing Cardiovascular Risk Reduction in High-Risk Patients: Focus on Strategies to Improve Non-HDL-Cholesterol Goal Attainment
Abbott, ECS
11/19/20, 12:00 AM
Asia/Dubai GMT+4
Description
ENDORSED BY THE EMIRATES CARDIAC SOCIETY
Date: November 18, 2020
Timings:
21:00-22:40 (GMT +4 Abu Dhabi, Muscat Time)
Speakers: Dr. Michel Farnier and Dr. Julian Halcox
Moderator: Dr. Abdullah Shehab
21:00-21:40
Importance of Management of Non-HDL Cholesterol for Better CV Risk Management
Presented by Dr. Michel Farnier
21:40-22:20
How to Incorporate Highly Purified N-3 AEEs for Optimizing CVD Prevention in High Risk Patients
Presented by Dr. Julian Halcox
22:20-22:40
Q&A
Questions and Answers will open to the audience
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Abdullah Shehab
Importance of Management of Non-HDL Cholesterol for Better CV Risk Management, How to Incorporate Highly Purified N-3 AEEs for Optimizing CVD Prevention in High Risk Patients, Q&A
Inglês
Speakers
Michel Farnier, Julian Halcox
Link to the Event
Banner to the Event
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.